Kidney Function After Islet Transplant Alone in Type 1 Diabetes | Zendy

Paola Maffi | Zendy; Federico Bertuzzi | Zendy; Francesca De Taddeo | Zendy; Paola Magistretti | Zendy; Rita Nano | Zendy; Paolo Fiorina | Zendy; Andrea Caumo | Zendy; Paolo Pozzi | Zendy; Carlo Socci | Zendy; Massimo Venturini | Zendy; Alessandro Del Maschio | Zendy; Antonio Secchi | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Kidney Function After Islet Transplant Alone in Type 1 Diabetes

Author(s) -

Paola Maffi,

Federico Bertuzzi,

Francesca De Taddeo,

Paola Magistretti,

Rita Nano,

Paolo Fiorina,

Andrea Caumo,

Paolo Pozzi,

Carlo Socci,

Massimo Venturini,

Alessandro Del Maschio,

Antonio Secchi

Publication year - 2007

Publication title -

diabetes care

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 6.636

H-Index - 363

eISSN - 1935-5548

pISSN - 0149-5992

DOI - 10.2337/dc06-1794

Subject(s) - medicine , immunosuppression , transplantation , islet , creatinine , tacrolimus , diabetes mellitus , urology , kidney transplantation , renal function , type 1 diabetes , urinary system , sirolimus , gastroenterology , kidney disease , type 2 diabetes , kidney , endocrinology

Islet transplantation alone is an alternative for the replacement of pancreatic endocrine function in patients with type 1 diabetes. The aim of our study was to assess the impact of the Edmonton immunosuppressive protocol (tacrolimus-sirolimus association) on kidney function.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research